Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

novartis_outside_1

Novartis signs $150 million deal with Xencor to develop bispecific antibodies

June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Novartis, Xencor, bispecific antibodies, deal, drug development, drug trial

Swiss drugmaker Novartis (VTX: NOVN) said it has signed a $150 million upfront collaboration and licensing agreement with Xencor to …
News
takeda_world

Takeda to return molecules/ products for Japan to Amgen

June 27, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, Japan, Takeda Pharmaceutical, drug development, drug trial

Japanese firm Takeda Pharmaceutical (TSE: 4502) said it will return the rights to develop and market multiple molecules/ products from …
News
brexit

“Immediate challenges” for UK pharma post-Brexit, says ABPI

June 24, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, brexit

The UK life sciences industry has expressed dismay at the result of the EU referendum, but has pledged to work …
News

Murdo Gordon gets Chief Commercial Officer role at Bristol-Myers Squibb

June 21, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, chief commercial officer

Bristol-Myers Squibb (NYSE: BMY) has announced the appointment of Munro Gordon as executive vice president and chief commercial officer, effective …
Appointment
amgen_flag

Amgen’s denosumab may help check breast cancer in women with BRCA1 gene – Study

June 21, 2016 Manufacturing and Production, Research and Development Amgen, Prolia, Xgeva, biotech, breast cancer, drug trial, genetics

US biotech firm Amgen’s (Nasdaq: AMGN) Prolia (denosumab) to treat osteoporosis and Xgeva to prevent fractures in cancer patients, may …
News
rd_hands

Auris Medical initiates Phase III trial for sudden deafness treatment

June 21, 2016 Manufacturing and Production, Research and Development auris medical, sudden deafness

Auris Medical (NASDAQ: EARS) has announced that it has initiated enrolment for a new Phase III trial that will evaluate …
News
novartis_side_building

Novartis aims to launch five major global biosimilars by 2020

June 21, 2016 Manufacturing and Production, Research and Development 2020, Novartis, Sandoz, biosimilars

Novartis (VTX: NOVN) has announced plans to triple its biosimilar portfolio by 2020, with the launch of five major biosimilar …
News
shutterstock_67313209

Doctors prescribe more brand drugs for free meals from pharma industry – Study

June 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing JAMA, regulation, research

Doctors who received free meals from the pharmaceutical representatives were more likely to prescribe the brand-name medication that was being …
News
aedes_aegypti_mosquito

First-in-man Zika vaccine trials get green light

June 21, 2016 Manufacturing and Production, Research and Development trials, zika vaccine

Inovio Pharmaceuticals (NASDAQ: INO) and GeneOne Life Science (KSE: 011000) have announced that approval has been granted for the commencement …
News
esteban

Amgen appoints Esteban Santos as executive VP of operations

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Amgen (NASDAQ: AMGN) has announced the appointment of Esteban Santos as executive vice president, operations. Santos will be responsible for …
Appointment
stocks1

Weekly Movers: Global Blood Therapeutics, Sophiris Bio…

June 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Global Blood Therapeutics, Shares, markets, pharma, stocks

Here’s a quick look at some of the biggest movers of the week:Sophiris Bio (Nasdaq: SPHS) stock rose to nearly …
Feature
pharma_pill_manufacturing

Valeant plots significant investment in Canadian operations

June 20, 2016 Manufacturing and Production, Sales and Marketing Canada, Valeant, manufacturing

Valeant Pharmaceuticals (NYSE: VRX) has announced that it plans to expand its Canadian operations with a $27.5 million expansion of …
News
janssen_latest_logo_on_sign_closer

Janssen says Imbruvica shows improved PFS in blood cancer in long-term effectiveness study

June 14, 2016 Manufacturing and Production, Research and Development Janssen, blood cancer, drug trial, imbruvica

Janssen said late-stage studies to test long-term effectiveness for its Imbruvica (ibrutinib) in blood cancer showed improved progression free survival …
News
stocks3

Marinus says will stop developing adult focal onset seizure drug as Phase III trials fail; shares plunge

June 14, 2016 Manufacturing and Production, Research and Development Drug-Resistant Epilepsy, Marinus Pharmaceuticals, drug trial, ganaxolone

Shares in Marinus Pharmaceuticals (Nasdaq: MRNS) more than halved in value Monday after the company said it plans to stop …
News
merckincweb

MSD insulin glargine biosimilar meets primary endpoint in late-stage trials

June 14, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Merck, biosimilar, insulin, insuline glargine

MSD (NYSE: MRK), known as Merck in the US and Canada, has announced results from two Phase III studies evaluating …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026